These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 5318637

  • 1. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
    Warembourg H, Jaillard J.
    Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of hyperlipidemia with the ethyl-ester of chlorophenoxyisobutyrate and androsterone.
    Schatz IJ.
    Henry Ford Hosp Med J; 1965 Dec; 13(4):447-56. PubMed ID: 5325188
    [No Abstract] [Full Text] [Related]

  • 3. [Results of atromid or CPIB treatment with and without androsterone in hyperlipemia (110 therapeutic trials in 2 years)].
    de Gennes JL, Maunand B, Salmon, Laudat P, Truffert J.
    Bull Mem Soc Med Hop Paris; 1965 Apr 30; 116(8):759-84. PubMed ID: 5834264
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL, Maunand B, Salmon D, Laudat P, Truffert J.
    Rev Atheroscler (Paris); 1966 Apr 30; 8(1):27-52. PubMed ID: 5961027
    [No Abstract] [Full Text] [Related]

  • 6. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood].
    Cloarec M, Cottet J, Etienne J, Loeper J.
    Sem Ther; 1965 Nov 30; 41(9):499-500. PubMed ID: 5877602
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV.
    Ter Arkh; 1968 Mar 30; 40(3):15-20. PubMed ID: 4875984
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical-experimental studies on lipid metabolism using Regelan].
    Hammerl H.
    Wien Klin Wochenschr; 1967 Sep 29; 79(39):720-2. PubMed ID: 4875575
    [No Abstract] [Full Text] [Related]

  • 9. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B, Monnier J.
    Praxis; 1969 Jun 24; 58(25):815-20. PubMed ID: 5819485
    [No Abstract] [Full Text] [Related]

  • 10. Hypolipidemic agents--newly approved.
    Duncan GG.
    Pa Med; 1967 Aug 24; 70(8):75-6. PubMed ID: 6073724
    [No Abstract] [Full Text] [Related]

  • 11. [CPIB: a hypolipidemic agent. Study of 20 patients].
    Verdy M.
    Union Med Can; 1966 Sep 24; 95(9):1049-52. PubMed ID: 5913817
    [No Abstract] [Full Text] [Related]

  • 12. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
    Braunsteiner H, Herbst M, Sandhofer F, Sailer S.
    Dtsch Med Wochenschr; 1967 Dec 15; 92(50):2302-8. PubMed ID: 6075896
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun 16; 9(12):45-7. PubMed ID: 6037633
    [No Abstract] [Full Text] [Related]

  • 15. [A case of essential hyperlipemia treated with atromid].
    Baczko A, Ciświcka-Sznajderman M, Jakubowicz K, Sznajderman M.
    Kardiol Pol; 1965 Jun 16; 8(2):135-41. PubMed ID: 5836657
    [No Abstract] [Full Text] [Related]

  • 16. Clinical trial with ethyl-a-p-chlorophenoxyisobutyrate (Atromid-S) with special reference to white blood cell counts.
    Engström J.
    Acta Med Scand; 1966 Nov 16; 180(5):519-31. PubMed ID: 5332263
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Familial hypercholesterolaemic xanthomatosis and coronary heart disease in a ten-year-old girl.
    Miettinen M.
    Ann Paediatr Fenn; 1967 Nov 16; 13(1):35-8. PubMed ID: 6079714
    [No Abstract] [Full Text] [Related]

  • 19. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
    Vannas S, Esilä R, Tuovinen E.
    Acta Ophthalmol (Copenh); 1968 Nov 16; 46(2):162-70. PubMed ID: 5755673
    [No Abstract] [Full Text] [Related]

  • 20. Trial of "Atheran" and "Atromid-S" in atherosclerosis.
    Barnett AJ, Carson V.
    Med J Aust; 1966 Jun 04; 1(23):965-70. PubMed ID: 5939995
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.